163 related articles for article (PubMed ID: 25929034)
1. [Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
Andronova VL; Jasko MV; Kukhanova MK; Skoblov YS; Deryabin PG; Galegov GA
Vopr Virusol; 2014; 59(6):32-5. PubMed ID: 25929034
[TBL] [Abstract][Full Text] [Related]
2. [The suppression of a herpes simplex virus reproduction with drug resistance by combination 15lys-bis-nt and phosphate of acycloguanosine with some antiherpetic drugs].
Andronova VL; Grokhovskiĭ SL; Deriabin PG; Gurskiĭ GV; Surovaia AN; Jas'ko MV; Kukhanova MK; Kochetkov SN; Skoblov IuS; Galegov GA
Vopr Virusol; 2014; 59(4):37-41. PubMed ID: 25549466
[TBL] [Abstract][Full Text] [Related]
3. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Schinazi RF; Nahmias AJ
Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of interferon-alpha and acyclovir on herpes simplex virus type 1 DNA polymerase and alkaline DNase.
Taylor JL; Tom P; O'Brien WJ
Antiviral Res; 1998 May; 38(2):95-106. PubMed ID: 9707372
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of the reproduction of strains of the herpes simplex virus type 1 with drug resistance].
Andronova VL; Galegov GA
Antibiot Khimioter; 2000; 45(1):5-9. PubMed ID: 10690421
[TBL] [Abstract][Full Text] [Related]
11. [Antiherpesviral activity of acycloguanosine H-phosphonate in experiments using laboratory animals].
Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Kochetkov SN; Skoblov IuS
Vopr Virusol; 2011; 56(5):37-40. PubMed ID: 22171477
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
13. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir, cidofovir, and amenamevir have additive antiviral effects on herpes simplex virus TYPE 1.
Greeley ZW; Giannasca NJ; Porter MJ; Margulies BJ
Antiviral Res; 2020 Apr; 176():104754. PubMed ID: 32114034
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB
Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489
[No Abstract] [Full Text] [Related]
16. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
17. [Research of suppression of the herpes simplex virus reproduction with drug resistance using a combination 15-Lys-bis-Nt with some antiherpetic drugs].
Andronova VL; Grokhovskiĭ SL; Surovaia AN; Deriabin PG; Gurskiĭ GV; Galegov GA
Vopr Virusol; 2014; 59(1):38-41. PubMed ID: 25065145
[TBL] [Abstract][Full Text] [Related]
18. Antiviral susceptibility of recombinant Herpes simplex virus 1 strains with specific polymerase amino acid changes.
Rose R; Brunnemann AK; Baukmann S; Bühler S; Fickenscher H; Sauerbrei A; Zell R; Krumbholz A
Antiviral Res; 2021 Nov; 195():105166. PubMed ID: 34419483
[TBL] [Abstract][Full Text] [Related]
19. CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections.
Prichard MN; Kern ER; Hartline CB; Lanier ER; Quenelle DC
Antimicrob Agents Chemother; 2011 Oct; 55(10):4728-34. PubMed ID: 21788472
[TBL] [Abstract][Full Text] [Related]
20. Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1.
Talarico LB; Castilla V; Ramirez JA; Galagovsky LR; Wachsman MB
Chemotherapy; 2006; 52(1):38-42. PubMed ID: 16340198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
